Presentations & Webcasts

View our latest presentations and webcasts.

Corporate Presentation

February 2023

SparingVision poster presentations at the American College of Toxicology’s annual meeting 2022

View Poster
View Poster

SparingVision presentations at the European Society for Gene and Cell Therapies’ annual meeting 2022

Chardan’s 6th Annual Genetic Medicines Conference,
October 4-5, 2022 : Company presentation

View Webcast

Jefferies Cell & Genetic Medicine Summit,
September 29, 2022: Company presentation

View Webcast

LifeSci 2nd Annual Genetic Medicines Symposium,
June 2022: Fireside chat

View Webcast

SPVN06 oral presentation at the American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting 2022

View Presentation

Gene Independent Approaches to Cone Photoreceptor Function Preservation- e-Poster presentation

Retina World Congress 2022

View Video

SPVN06 presentations at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting

View Poster
View Poster
View Presentation

Oppenheimer Fireside Chat : The Future of Gene Therapy and Gene Editing in Ophthalmology, January 2022

View Webcast

Intellia Therapeutics and SparingVision Announce Strategic Collaboration

Intellia Therapeutics and SparingVision Announce Strategic Collaboration – webcast

View Webcast
View PDF

Gamut acquisition webcast

View Webcast
View PDF

SparingVision announces acquisition of GAMUT Therapeutics

SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer

Menu
Latest Tweets

Last Saturday was International Day of Women and Girls in Science. At SparingVision we like to recognize the importance of having a diverse team and recognize this important day. Hear from some of the women at SparingVision!

Excited to be listed by @BioBuzz in their "5 Philly Life Sciences Companies We're Watching in H1 2023." Proud to be part of the thriving #PhillyLifeSciences community! #GenomicMedicines #Ophthalmology #GeneTherapy #GenomeEditing

Read more: https://biobuzz.io/5-philly-life-sciences-companies-were-watching-in-h1-2023/

PARTNERS